Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Serpentine transmembrane antigens expressed in human cancers and uses thereof

Serpentine transmembrane antigens expressed in human cancers and uses thereof

US Patent 7319006 · Granted Jan 15, 2008

Estimated economic value: $63,223,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Borylated amino acid compositions for use in boron neutron capture therapy and m2024
Borylated amino acid compositions for use in boron neutron capture therapy and m2023
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins2022
Anti-PD-1 antibodies and their uses2020
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins2020
Anti-PD-1 antibodies and their uses2018
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins2017
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins2015
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins2015
Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and2015
Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and2015
Prostate stem cell antigen (PSCA) variants and subsequences thereof2014